Horizon Therapeutics (F/K/A) Horizon Pharma USA INC
Biopharmaceutical company
Based in IL
🤖
AI Overview
With $1.4M in lobbying spend across 25 quarterly filings, Horizon Therapeutics (F/K/A) Horizon Pharma USA INC is a significant lobbying presence. Their lobbying covers 3 issue areas. Active from 2018 to 2023.
$1.4M
Total Spend
6
Years Active
1
Firms Hired
5
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $330K |
| 2019 | $240K |
| 2020 | $220K |
| 2021 | $180K |
| 2022 | $160K |
| 2023 | $300K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Taxation, Pharmacy, Medicare/Medicaid
- •Tax Reform, generally; HR 1, An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018 (Tax Cuts and Jobs Act).
- •340B Refprm; drug pricing and general pharmaceutical issues; 340B definition of "Patient;"
- •Executive order on Drug Pricing
- •340B Reform; drug pricing and general pharmaceutical issues; 340B definition of "Patient;"
- •Executive order on Drug Pricing; Administration Prescription Drug Policy.
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.